Results 141 to 150 of about 162,990 (305)

Additional file 2: of High-intensity interval training and moderate-intensity continuous training in adults with Crohnâ s disease: a pilot randomised controlled trial

open access: yes, 2019
Summary of recruitment survey data. (DOCX 12 kb)
Tew, Garry   +10 more
openaire   +1 more source

Radiologic, Histologic and Scanning Electron Microscopic Characterization of the Peritoneal Reflection in Crohn's Disease

open access: yesClinical Anatomy, EarlyView.
ABSTRACT The peritoneal reflection bridges visceral and parietal peritoneum and lacks adjoining or underlying organs. As such it provides an opportunity to perform a focussed examination of the peritoneum in Crohn's disease. The aim of this study was to exploit this anatomical property and conduct a multilayered, focussed examination of the peritoneal ...
L. Walsh   +4 more
wiley   +1 more source

Additional file 1: of Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease

open access: yes, 2018
Figure S1. Stacked bar-chart showing the relative abundance of microbial classes across the metagenomic sequencing data. Figure S2. Stacked bar-chart showing the relative abundance of bacterial classes across the 16S rRNA gene sequencing data. Figure S3.
Douglas, Gavin   +11 more
openaire   +1 more source

Intraosseous sarcoidosis imitating peri‐implantitis: A case study

open access: yesClinical Advances in Periodontics, EarlyView.
Abstract Background Sarcoidosis is a multisystem granulomatous disorder of unknown cause, typically affecting the lungs and lymph nodes, but it can also involve the eyes, skin, heart, bones, and other organs. The exact cause is unclear, but genetic factors and environmental triggers like infections, chemicals, or dust may play a role.
Magdalena Orlowska   +2 more
wiley   +1 more source

Additional file 1: of Multimodal treatment of perianal fistulas in Crohnâ s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial

open access: yes, 2015
Dates of consent of participating centres.
E. De Groof   +39 more
openaire   +1 more source

Financial Toxicity Associated with Biological Medicines: A Scoping Review

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Financial toxicity, defined as the economic burden experienced by patients due to medication and other healthcare costs and their consequences, such as material, psychosocial and behavioral effects, represents a significant concern for individuals receiving biological medicines.
Laura Sara Maria Saarukka   +4 more
wiley   +1 more source

Additional file 3: of Prognostic biomarkers to identify patients destined to develop severe Crohnâ s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation

open access: yes, 2016
Draft search strategy to be used for the PUBMED online database. (DOCX 104 kb)
Halligan, Steve   +7 more
openaire   +1 more source

Clinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Traditional dosing strategies often rely on a “one‐size‐fits‐all” paradigm, assuming an “average” patient with typical demographic and pharmacological characteristics. In reality, this often overlooks existing between‐patient variability and can lead to suboptimal drug exposure or toxicity. This issue is especially pronounced in pediatric patients, who
Zachary L. Taylor   +12 more
wiley   +1 more source

Additional file 1: of Could Mycobacterium avium subspecies paratuberculosis cause Crohnâ s disease, ulcerative colitisâ Śand colorectal cancer?

open access: yes, 2018
Descriptions and illustrations of the goblet cell hyperplasia lesion. The supplementary file discusses the descriptions and illustrations of the goblet cell hyperplasia lesion found in some of the references in the main text. (DOC 200 kb)
openaire   +1 more source

Additional file 2: of Prognostic biomarkers to identify patients destined to develop severe Crohnâ s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation

open access: yes, 2016
PRISMA-P 2015 Checklist. (DOCX 31 kb)
Halligan, Steve   +7 more
openaire   +1 more source

Home - About - Disclaimer - Privacy